Lipid abnormalities in the metabolic syndrome (Q35087481)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Lipid abnormalities in the metabolic syndrome	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Lipid abnormalities in the metabolic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

Eliot A Brinton

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Current diabetes report

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

65-72

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

The triglyceride issue revisited. Findings from the Helsinki Heart Study.

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0056-3

21 January 2018

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of dyslipidemia in NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and all-cause and coronary heart disease mortality among US male physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abdominal adiposity and coronary heart disease in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood-sugar and arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12643148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11892-003-0056-3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35087481&oldid=2197231628"